164 related articles for article (PubMed ID: 17669370)
1. Allosteric effects of antagonists on signalling by the chemokine receptor CCR5.
Haworth B; Lin H; Fidock M; Dorr P; Strange PG
Biochem Pharmacol; 2007 Sep; 74(6):891-7. PubMed ID: 17669370
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of the chemokine receptor, CCR5.
Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
[TBL] [Abstract][Full Text] [Related]
3. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
Leach K; Charlton SJ; Strange PG
Biochem Pharmacol; 2007 Sep; 74(6):881-90. PubMed ID: 17645873
[TBL] [Abstract][Full Text] [Related]
4. Diverse signalling by different chemokines through the chemokine receptor CCR5.
Mueller A; Mahmoud NG; Strange PG
Biochem Pharmacol; 2006 Sep; 72(6):739-48. PubMed ID: 16844091
[TBL] [Abstract][Full Text] [Related]
5. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
Andrews G; Jones C; Wreggett KA
Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
[TBL] [Abstract][Full Text] [Related]
6. CCR5 internalisation and signalling have different dependence on membrane lipid raft integrity.
Cardaba CM; Kerr JS; Mueller A
Cell Signal; 2008 Sep; 20(9):1687-94. PubMed ID: 18573334
[TBL] [Abstract][Full Text] [Related]
7. pH-independent endocytic cycling of the chemokine receptor CCR5.
Signoret N; Christophe T; Oppermann M; Marsh M
Traffic; 2004 Jul; 5(7):529-43. PubMed ID: 15180829
[TBL] [Abstract][Full Text] [Related]
8. The relative activity of "function sparing" HIV-1 entry inhibitors on viral entry and CCR5 internalization: is allosteric functional selectivity a valuable therapeutic property?
Muniz-Medina VM; Jones S; Maglich JM; Galardi C; Hollingsworth RE; Kazmierski WM; Ferris RG; Edelstein MP; Chiswell KE; Kenakin TP
Mol Pharmacol; 2009 Mar; 75(3):490-501. PubMed ID: 19064629
[TBL] [Abstract][Full Text] [Related]
9. Effect of CCR5 receptor antagonists on endocytosis of the human CCR5 receptor in CHO-K1 cells.
Longden J; Cooke EL; Hill SJ
Br J Pharmacol; 2008 Apr; 153(7):1513-27. PubMed ID: 18223665
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization.
Zhao J; Ma L; Wu YL; Wang P; Hu W; Pei G
J Cell Biochem; 1998 Oct; 71(1):36-45. PubMed ID: 9736452
[TBL] [Abstract][Full Text] [Related]
11. Distinct modes of molecular regulation of CCL3 induced calcium flux in monocytic cells.
Cardaba CM; Mueller A
Biochem Pharmacol; 2009 Oct; 78(8):974-82. PubMed ID: 19523456
[TBL] [Abstract][Full Text] [Related]
12. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers.
El-Asmar L; Springael JY; Ballet S; Andrieu EU; Vassart G; Parmentier M
Mol Pharmacol; 2005 Feb; 67(2):460-9. PubMed ID: 15509716
[TBL] [Abstract][Full Text] [Related]
13. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
[TBL] [Abstract][Full Text] [Related]
14. Selection of CC chemokine receptor 5-binding peptide from a phage display peptide library.
Wang FY; Zhang TY; Luo JX; He GA; Gu QL; Xiao F
Biosci Biotechnol Biochem; 2006 Sep; 70(9):2035-41. PubMed ID: 16960395
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inverse agonist action at D2 dopamine receptors.
Roberts DJ; Strange PG
Br J Pharmacol; 2005 May; 145(1):34-42. PubMed ID: 15735658
[TBL] [Abstract][Full Text] [Related]
16. The activation mechanism of chemokine receptor CCR5 involves common structural changes but a different network of interhelical interactions relative to rhodopsin.
Springael JY; de Poorter C; Deupi X; Van Durme J; Pardo L; Parmentier M
Cell Signal; 2007 Jul; 19(7):1446-56. PubMed ID: 17320349
[TBL] [Abstract][Full Text] [Related]
17. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.
Mack M; Luckow B; Nelson PJ; Cihak J; Simmons G; Clapham PR; Signoret N; Marsh M; Stangassinger M; Borlat F; Wells TN; Schlöndorff D; Proudfoot AE
J Exp Med; 1998 Apr; 187(8):1215-24. PubMed ID: 9547333
[TBL] [Abstract][Full Text] [Related]
18. The molecular cloning and functional expression of the dog CCR5.
Mosley M; Pullen S; Botham A; Gray A; Napier C; Mansfield R; Holbrook M
Vet Immunol Immunopathol; 2006 Oct; 113(3-4):415-20. PubMed ID: 16806494
[TBL] [Abstract][Full Text] [Related]
19. The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor.
Watson C; Jenkinson S; Kazmierski W; Kenakin T
Mol Pharmacol; 2005 Apr; 67(4):1268-82. PubMed ID: 15644495
[TBL] [Abstract][Full Text] [Related]
20. Segment-dependent activation of muscarinic acetylcholine receptor-mediated [35S]Guanosine-5'-O-(gamma-thiotriphosphate) binding in airway tissue membranes.
Hajek P; Ungemach FR; Abraham G
Pharmacology; 2009; 83(4):247-58. PubMed ID: 19295255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
